{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:16:34Z","timestamp":1781043394296,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background and aim<\/jats:title>\n                <jats:p>Ultrasound-guided radiofrequency ablation (RFA) is a minimally invasive therapy for thyroid nodules (TNs). Understanding the determinants of RFA efficacy can improve treatment and prognosis. This study aims to investigate the relationship between ultrasound parameters of benign TNs and the efficacy of RFA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A pretest\u2013posttest interventional study was conducted in 2021 on 250 randomly sampled patients with benign TNs, receiving RFA. For this purpose, the volume reduction (VR) and the VR ratio (VRR) of the nodules were measured at the 1-, 3-, 6-, and 12-month follow-up periods after the RFA completion. The technical success rate (TSR) of this procedure was then categorized into four states, including low (VRR\u2009&lt;\u200925%), moderate (VRR\u2009=\u200925\u201349%), high (VRR\u2009=\u200950\u201374%), and very high (VRR\u2009\u2265\u200975). Ordered logistic regression (OLR) was further utilized to investigate the effect of the ultrasound parameters of TNs on the TSR. The analyses were notably performed using Stata 14.2.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The VRR at the 1-, 3-, 6-, and 12-month follow-up periods were 38.7%, 53.6%, 59.3%, and 59.9%, respectively. The mean VR was also statistically significant at all follow-ups (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). At the 1-, 3-, and 6-month follow-up periods, the VR of over 50% was observed in 28.2%, 52.1%, and 65.2% of the nodules, respectively. The odds ratios (ORs) of the RFA success were found to be 4.3 times higher for the nodules in the left lobe compared to the right lobe (OR: 4.31, <jats:italic>p<\/jats:italic>\u2009=\u20090.002), 6.3 times greater for isoechoic nodules compared to hyperechoic nodules (OR: 6.39, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), 6.2 times higher for hyper-vascular nodules compared to hypo-vascular nodules (OR: 6.25, <jats:italic>p<\/jats:italic>\u2009=\u20090.005), and 2.3 times greater for mixed nodules compared to solid ones (OR: 2.37, <jats:italic>p<\/jats:italic>\u2009=\u20090.049).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The ultrasound parameters of TNs had a statistically significant effect on the efficacy of RFA. Small-sized, isoechoic, and hyper-vascular nodules, as well as those with mixed tissue, were observed to respond better to RFA, leading to a better prognosis in terms of VR after treatment.\n<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12880-023-01044-z","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T09:02:14Z","timestamp":1687165334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effect of ultrasound parameters of benign thyroid nodules on radiofrequency ablation efficacy"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3815-776X","authenticated-orcid":false,"given":"Zahra","family":"Motaghed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Chegeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mosadeghkhah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Azimi Aval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Gerami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hojat","family":"Ebrahiminik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"issue":"3","key":"1044_CR1","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s12020-017-1285-6","volume":"56","author":"G Panagiotou","year":"2017","unstructured":"Panagiotou G, et al. Association between lifestyle and anthropometric parameters and thyroid nodule features. Endocrine. 2017;56(3):560\u20137.","journal-title":"Endocrine"},{"issue":"3","key":"1044_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00423-016-1408-1","volume":"401","author":"E Aysan","year":"2016","unstructured":"Aysan E, et al. Single-session radiofrequency ablation on benign thyroid nodules: a prospective single center study. Langenbecks Arch Surg. 2016;401(3):357\u201363.","journal-title":"Langenbecks Arch Surg"},{"issue":"1","key":"1044_CR3","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1080\/02656736.2019.1627432","volume":"36","author":"A Ben Hamou","year":"2019","unstructured":"Ben Hamou A, et al. Safety and efficacy of thermal ablation (radiofrequency and laser): should we treat all types of thyroid nodules? Int J Hyperth. 2019;36(1):665\u201375.","journal-title":"Int J Hyperth"},{"issue":"4","key":"1044_CR4","first-page":"413","volume":"48","author":"J Stani\u010di\u0107","year":"2009","unstructured":"Stani\u010di\u0107 J, et al. Thyroid nodularity-true epidemic or improved diagnostics. Acta Clin Croat. 2009;48(4):413\u20137.","journal-title":"Acta Clin Croat"},{"issue":"1","key":"1044_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-5338-5","volume":"19","author":"Y Guang","year":"2019","unstructured":"Guang Y, et al. Patient satisfaction of radiofrequency ablation for symptomatic benign solid thyroid nodules: our experience for 2-year follow up. BMC Cancer. 2019;19(1):1\u20138.","journal-title":"BMC Cancer"},{"issue":"3","key":"1044_CR6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.anl.2012.09.007","volume":"40","author":"M Kihara","year":"2013","unstructured":"Kihara M, et al. Evaluation of cytologically benign solitary thyroid nodules by ultrasonography: a retrospective analysis of 1877 cases. Auris Nasus Larynx. 2013;40(3):308\u201311.","journal-title":"Auris Nasus Larynx"},{"issue":"1","key":"1044_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jamcollsurg.2013.03.014","volume":"217","author":"S Lee","year":"2013","unstructured":"Lee S, et al. The biopsy-proven benign thyroid nodule: is long-term follow-up necessary? J Am Coll Surg. 2013;217(1):81\u20138.","journal-title":"J Am Coll Surg"},{"issue":"1","key":"1044_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.otohns.2007.09.015","volume":"138","author":"M Vaiman","year":"2008","unstructured":"Vaiman M, et al. Hypothyroidism following partial thyroidectomy. Otolaryngol Head Neck Surg. 2008;138(1):98\u2013100.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"1044_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.14366\/usg.18044","volume":"38","author":"J-H Kim","year":"2019","unstructured":"Kim J-H, et al. Summary of the 2017 thyroid radiofrequency ablation guideline and comparison with the 2012 guideline. Ultrasonography. 2019;38(2):125.","journal-title":"Ultrasonography"},{"issue":"6","key":"1044_CR10","doi-asserted-by":"publisher","first-page":"e0179387","DOI":"10.1371\/journal.pone.0179387","volume":"12","author":"S Jegerlehner","year":"2017","unstructured":"Jegerlehner S, et al. Overdiagnosis and overtreatment of thyroid cancer: a population-based temporal trend study. PLoS One. 2017;12(6):e0179387.","journal-title":"PLoS ONE"},{"issue":"4","key":"1044_CR11","doi-asserted-by":"publisher","first-page":"e013589","DOI":"10.1136\/bmjopen-2016-013589","volume":"7","author":"M Mathonnet","year":"2017","unstructured":"Mathonnet M, et al. What is the care pathway of patients who undergo thyroid surgery in France and its potential pitfalls? A national cohort. BMJ Open. 2017;7(4):e013589.","journal-title":"BMJ Open"},{"issue":"1","key":"1044_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12020-016-0967-9","volume":"54","author":"N Singh Ospina","year":"2016","unstructured":"Singh Ospina N, et al. Prognosis of patients with benign thyroid nodules: a population-based study. Endocrine. 2016;54(1):148\u201355.","journal-title":"Endocrine"},{"issue":"3","key":"1044_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1148\/radiology.217.3.r00dc26633","volume":"217","author":"GS Gazelle","year":"2000","unstructured":"Gazelle GS, et al. Tumor ablation with radio-frequency energy. Radiology. 2000;217(3):633\u201346.","journal-title":"Radiology"},{"issue":"6","key":"1044_CR14","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1007\/s00330-008-0880-6","volume":"18","author":"WK Jeong","year":"2008","unstructured":"Jeong WK, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol. 2008;18(6):1244\u201350.","journal-title":"Eur Radiol"},{"issue":"5","key":"1044_CR15","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.ultrasmedbio.2007.10.018","volume":"34","author":"M Deandrea","year":"2008","unstructured":"Deandrea M, et al. US-guided percutaneous radiofrequency thermal ablation for the treatment of solid benign hyperfunctioning or compressive thyroid nodules. Ultrasound Med Biol. 2008;34(5):784\u201391.","journal-title":"Ultrasound Med Biol"},{"issue":"4","key":"1044_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3348\/kjr.2017.18.4.615","volume":"18","author":"HS Park","year":"2017","unstructured":"Park HS, et al. Thyroid radiofrequency ablation: updates on innovative devices and techniques. Korean J Radiol. 2017;18(4):615\u201323.","journal-title":"Korean J Radiol"},{"issue":"9","key":"1044_CR17","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jama.2018.0898","volume":"319","author":"C Durante","year":"2018","unstructured":"Durante C, et al. The diagnosis and management of thyroid nodules: a review. JAMA. 2018;319(9):914\u201324.","journal-title":"JAMA"},{"issue":"7","key":"1044_CR18","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1007\/s00330-020-07532-y","volume":"31","author":"M Deandrea","year":"2021","unstructured":"Deandrea M, et al. Determining an energy threshold for optimal volume reduction of benign thyroid nodules treated by radiofrequency ablation. Eur Radiol. 2021;31(7):5189\u201397.","journal-title":"Eur Radiol"},{"issue":"2","key":"1044_CR19","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s12020-018-1829-4","volume":"64","author":"GM Lee","year":"2019","unstructured":"Lee GM, et al. Successful radiofrequency ablation strategies for benign thyroid nodules. Endocrine. 2019;64(2):316\u201321.","journal-title":"Endocrine"},{"key":"1044_CR20","doi-asserted-by":"publisher","unstructured":"Ebrahiminik H, et al. Radiofrequency ablation of benign thyroid nodules: initial clinical experience in Iran.\u00a0Iran J Radiol. 2017;Special issue(5):e48418. https:\/\/doi.org\/10.5812\/iranjradiol.48418.","DOI":"10.5812\/iranjradiol.48418"},{"key":"1044_CR21","doi-asserted-by":"publisher","first-page":"638880","DOI":"10.3389\/fendo.2021.638880","volume":"12","author":"A Bisceglia","year":"2021","unstructured":"Bisceglia A, et al. Predictor analysis in radiofrequency ablation of benign thyroid nodules: a single center experience. Front Endocrinol. 2021;12:638880.","journal-title":"Front Endocrinol"},{"issue":"1","key":"1044_CR22","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1080\/02656736.2021.1993358","volume":"38","author":"C-Y Kuo","year":"2021","unstructured":"Kuo C-Y, et al. Learning curve analysis of radiofrequency ablation for benign thyroid nodules. Int J Hyperth. 2021;38(1):1536\u201340.","journal-title":"Int J Hyperth"},{"key":"1044_CR23","doi-asserted-by":"publisher","first-page":"7556393","DOI":"10.1155\/2021\/7556393","volume":"2021","author":"VB Nguyen","year":"2021","unstructured":"Nguyen VB, et al. Efficacy and safety of single-session radiofrequency ablation in treating Benign thyroid nodules: a short-term prospective cohort study. Int J Endocrinol. 2021;2021:7556393.","journal-title":"Int J Endocrinol"},{"issue":"1","key":"1044_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s00268-021-06340-9","volume":"46","author":"C-Y Kuo","year":"2022","unstructured":"Kuo C-Y, et al. Computer-analyzed ultrasound predictors of the treatment efficacy of radiofrequency ablation for benign thyroid nodules. World J Surg. 2022;46(1):112\u201320.","journal-title":"World J Surg"},{"issue":"4","key":"1044_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1089\/thy.2006.16.361","volume":"16","author":"Y-S Kim","year":"2006","unstructured":"Kim Y-S, et al. Radiofrequency ablation of benign cold thyroid nodules: initial clinical experience. Thyroid. 2006;16(4):361\u20137.","journal-title":"Thyroid"},{"issue":"4","key":"1044_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1177\/1553350620913134","volume":"27","author":"F Feroci","year":"2020","unstructured":"Feroci F, et al. Radiofrequency thermal ablation of benign thyroid nodules: the correlation between ultrasound nodule characteristics and results. Surgical Innovation. 2020;27(4):342\u201351.","journal-title":"Surgical Innovation"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-023-01044-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-023-01044-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-023-01044-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T09:09:32Z","timestamp":1687165772000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-023-01044-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1044"],"URL":"https:\/\/doi.org\/10.1186\/s12880-023-01044-z","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,19]]},"assertion":[{"value":"29 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in compliance with all the principles of professional and scientific ethics along with the full observance of the confidentiality of patient information. Informed consent was further obtained from all participants. All experimental protocols were additionally approved by the Iran National Committee for Ethics in Biomedical Research with the code no. IR.AJAUMS.REC.1400.071, ensuring adherence to the guidelines set forth by this committee. Furthermore, the study followed relevant international clinical practice guidelines for radiofrequency ablation of benign thyroid nodules, to ensure the ethical conduct of the research and protection of human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}